Diagnosis Hospital Manufacturing Provider 
The Medical Futurist
JUNE 17, 2025
For dentists, it’s transforming diagnosis, decision-making, and treatment planning. Smart toothbrush While AI helps dental professionals provide better treatments, smart toothbrushes enable all of us to take better care of our teeth. In comparison, the first VR-recorded surgery was performed at the Royal London Hospital in 2016.
The Medical Futurist
JUNE 21, 2025
It will break language barriers These M-LLMs will easily facilitate communication between healthcare providers and patients who speak different languages, translating between various languages in real time. AI used in the hospital. Just as we’ve seen how live translation works with ChatGPT-4o.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
The Medical Futurist
JUNE 21, 2025
In 2016, The Guardian reported that a blind woman suffering from this disease was fitted with the implant labelled “bionic eye” in the UK as part of a trial at the Oxford Eye Hospital. The journal Nature provided a commentary report on HKUST’s research into the bionic eye. That must have been truly amazing!
FDA Law
JUNE 22, 2023
He also identified “Next-Generation Home-based Testing Technologies, including new IVDs, Digital Lateral Flow Readers, and Reporting Technologies” as an opportunity to “extend care from the hospital and clinic into the home setting.” HbA1c, diagnosis of a particular virus, etc.). seeking treatment).
FDA Law
SEPTEMBER 30, 2024
CMS did not finalize the price verification survey, which would have required manufacturers of 10 costly drugs selected annually to provide clinical information as well as information on production, distribution, research, and marketing costs, revenue and profit, and ex-U.S. Remarkably, manufacturers may not dispute a CMS notification.
FDA Law
OCTOBER 17, 2023
Non-Addictive Medical Products to Treat Pain or Addiction The SUPPORT Act ( Public Law 115-271 ) mandated that FDA issue a guidance document to provide information on how the Agency can apply section 515B of the FD&C Act to non-addictive medical products intended to treat pain or addiction.
FDA Law
JANUARY 18, 2024
whether growing or not; its seeds; resin extracted from any part; and every compound, manufacture, salt, derivative, mixture, or preparation of the plant, its seeds or resin. “Marijuana,” subject to the rescheduling recommendation, means all parts of the plant Cannabis sativa L., 21 U.S.C. § 802(16)(A). 21 U.S.C. § 802(16)(B).
Expert insights. Personalized for you.
126 
Let's personalize your content